AbbVie
ABBV
1,435 hedge funds and large institutions have $58.2B invested in AbbVie in 2013 Q4 according to their latest regulatory filings, with 192 funds opening new positions, 453 increasing their positions, 606 reducing their positions, and 38 closing their positions.
405% more first-time investments, than exits
New positions opened: 192 | Existing positions closed: 38
95% more call options, than puts
Call options by funds: $411M | Put options by funds: $211M
40% more funds holding in top 10
Funds holding in top 10: 42 → 59 (+17)
19% more capital invested
Capital invested by funds: $49B → $58.2B (+$9.16B)
11% more funds holding
Funds holding: 1,297 → 1,435 (+138)
0.04% more ownership
Funds ownership: 69.02% → 69.06% (+0.04%)
25% less repeat investments, than reductions
Existing positions increased: 453 | Existing positions reduced: 606
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$647M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$209M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$209M |
| 4 |
Morgan Stanley
New York
|
+$173M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$141M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$330M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$237M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$202M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$182M |
| 5 |
JP Morgan Chase
New York
|
-$148M |
ABBV Hedge Fund Activity: Q4 2013 in Review
1,435 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q4 2013, worth a combined $58.2B — up 19% from $49B a quarter earlier.
Buyers outnumbered sellers: 192 funds opened new ABBV positions and 38 closed out — a net gain of 154 holders — while 453 added to existing stakes and 606 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $647M. The largest seller was Wellington Management Group, cutting an estimated $330M.
- 1,435 institutional investors held AbbVie (ABBV) as of Q4 2013, up from 1,297 in Q3 2013.
- Funds reported $58.2B of AbbVie stock for Q4 2013, up 19% quarter-over-quarter.
- 192 funds opened new AbbVie positions in Q4 2013 and 38 closed out, a net change of +154 holders.
- The largest AbbVie buyer in Q4 2013 was Fidelity Investments, an estimated $647M added.
- The largest AbbVie seller in Q4 2013 was Wellington Management Group, an estimated $330M sold.
Based on aggregated 13F filings for Q4 2013.